Companies / Roche

Roche

Company
Related drugs
17
Related conditions
24

Recent developments

Biotech Deal Boom, Regulatory Advances, and CRISPR Pipeline Progress theglobeandmail.com ↗
Roche Appoints Mark Dawson as Head of Pharma Research and Early Development oncodaily.com ↗
Pharma Earnings Roundup: Alnylam, Neurocrine, AbbVie, Merck, Roche Miss Expectations biopharmadive.com ↗
Alnylam Q4 Earnings Beat, Revenue Misses on 85% Growth; Stock Down 4.1% genengnews.com ↗
Roche Stock Trades Steady as Pharma and Diagnostics Support Mid-CHF 60B Revenue theglobeandmail.com ↗
Hengrui Gets NMPA Nod for ADC Phase II Trial, Reports Positive Obesity Data hcplive.com ↗
CAM Use Tied to Higher Breast Cancer Death Risk; New Molecule Shows Promise Against Triple-Negative Tumors jamanetwork.com ↗
US Tariff Plan Spurs Massive Pharma Investment Wave, Indian Generics on Notice pharma.economictimes.indiatimes.com ↗
Lilly Amasses $1.5B Stockpile for Oral Obesity Drug as Logistics and Amylin Sectors Surge pharmaceuticalcommerce.com ↗
Roche's Experimental Breast Cancer Drug Giredestrant Fails Phase 3 Trial statnews.com ↗

Headlines link to the original publisher. Sources limited to a reviewed list of journals, regulators, and medical press.